-
Sleep disordered breathing occurs in most acute stroke patients and may contribute to morbidity
-
Preliminary data indicate that the prevalence of influenza A (H1N1) virus strains resistant to the antiviral medication oseltamivir is high. Therefore, interim guidelines issued by the CDC are to use zanamivir or a combination of oseltamivir and rimantidine if influenza A (H1N1) infection is suspected.
-
Nucleic acid amplification (NAA) testing should be performed on at least one respiratory specimen from each patient with signs and symptoms of pulmonary TB for whom a diagnosis of TB is being considered but has not yet been established, and for whom the test result would alter case management or TB control activities.
-
In this issue: Individualization of therapy with pharmacogenetics; the rate vs rhythm debate; the FDA's Risk Evaluation and Mitigation Strategy; FDA actions.
-
The goals of this study were fourfold: 1) to increase implementation rates of evidence-based interventions that have been shown to reduce ICU mortality and morbidity; 2) to design tools to promote team communication and team building; 3) to develop prompts that could be incorporated into an ICU progress note to promote consistent use of these measures; and 4) to provide "real time"' feedback regarding progress.
-
To determine whether relationships existed between the use of clinical information technology (CIT) and measures of patient outcomes, Amarasingham and colleagues conducted a cross-sectional study of urban hospitals in Texas using the questionnaire-based Clinical Information Technology Assessment Tool, which measures a hospital's level of automation based on the interactions of its physicians with the information system.
-
The effects of selective digestive tract decontamination (SDD) and selective oropharyngeal decontamination (SOD; SDD without systemic antibiotics), which are measures for preventing ICU-acquired infections, on patient outcomes and microbial resistance patterns remain unsettled and controversial.
-
-
-
Patman and associates at the Lung Institute of Western Australia in Perth undertook this study to determine whether the routine, intensive administration of chest physiotherapy (PT) to mechanically ventilated patients with severe acute brain injury would prevent the occurrence of ventilator-associated pneumonia (VAP), or speed its resolution once it was present.